HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
HTL Biotechnology offers expert guidance and support to companies venturing into the industrial production of a modified Hyaluronic Acid compound, ensuring transparent and efficient processes.
Design Innovative Functionalized HA
Process Development Scale Up to GMP process
HTL’s regulatory team provides essential support, ensuring development aligns with international standards for medical devices and drugs. Their expertise guarantees compliance throughout the process, delivering safe and effective products.